Salvia lachnostachys Benth has antitumor and chemopreventive effects against solid Ehrlich carcinoma
Salvia lachnostachys is an herbaceous plant with anti-inflammatory, analgesic and cytotoxic properties. This study investigated the antitumor effect of an ethanolic extract of Salvia lachnostachys leaves (EES) in a solid Ehrlich carcinoma model. Ehrlich cells were inoculated subcutaneously in the ri...
Saved in:
| Published in: | Molecular Biology Reports Vol. 46; no. 5; pp. 4827 - 4841 |
|---|---|
| Main Authors: | , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Dordrecht
Springer Science and Business Media LLC
01.10.2019
Springer Netherlands Springer Nature B.V |
| Subjects: | |
| ISSN: | 0301-4851, 1573-4978, 1573-4978 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Salvia lachnostachys
is an herbaceous plant with anti-inflammatory, analgesic and cytotoxic properties. This study investigated the antitumor effect of an ethanolic extract of
Salvia lachnostachys
leaves (EES) in a solid Ehrlich carcinoma model. Ehrlich cells were inoculated subcutaneously in the right pelvic member (2 × 10
6
cells) in female Swiss mice. The animals were treated with vehicle (10 mL kg
−1
, p.o.), EES (30 and 100 mg kg
−1
, p.o.), or methotrexate (2.5 mg kg
−1
, i.p.) for 21 days (early treatment) or 14 days (late treatment) after tumor inoculation, or 10 days before tumor inoculation and continued for 21 days after tumor inoculation (chemopreventive treatment). The acute toxicity test was performed according OECD guidelines Late treatment with EES had no antitumor effect. Early treatment with 100 mg kg
−1
EES prevented tumor development, increased tumor necrosis factor-α (TNF-α) levels and decreased tumor superoxide dismutase (SOD) activity, interleukin-10 (IL-10) levels and
Cyclin D1
expression, and tumor cell necrosis was observed. Chemopreventive treatment with EES for 10 and 31 days prevented tumor development in the same manner. EES treatment for 31 days decreased hepatic and tumor SOD activity, tumor IL-10 levels and
Cyclin D1
expression, and increased tumor reduced glutathione,
N
-acetylglucosaminidase, reactive oxygen species, lipid peroxidation, TNF-α levels and
Nrf2
expression. No toxicity was observed in the acute toxicity assay. In conclusion, EES had an antitumor effect by inhibiting
Cyclin D1
expression and increasing inflammation with early and chemopreventive treatment. Modulation of the antioxidant system also contribute for the antitumor effects of EES. |
|---|---|
| Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
| ISSN: | 0301-4851 1573-4978 1573-4978 |
| DOI: | 10.1007/s11033-019-04931-3 |